Comment on

• Outcome in juvenile onset systemic lupus erythematosus.

  Ravelli A, Ruperto N, Martini A. Ravelli A, et al. Curr Opin Rheumatol. 2005 Sep;17(5):568-73. doi: 10.1097/01.bor.0000169364.69066.1e. Curr Opin Rheumatol. 2005. PMID: 16093835 Review.
• Imaging in juvenile arthritis.

  Graham TB. Graham TB. Curr Opin Rheumatol. 2005 Sep;17(5):574-8. doi: 10.1097/01.bor.0000169365.46196.b6. Curr Opin Rheumatol. 2005. PMID: 16093836 Review.
• Caspase recruitment domain 15 mutations and rheumatic diseases.

  Rose CD, Martin TM. Rose CD, et al. Curr Opin Rheumatol. 2005 Sep;17(5):579-85. doi: 10.1097/01.bor.0000169362.61443.52. Curr Opin Rheumatol. 2005. PMID: 16093837 Review.
• Recent developments in immunomodulatory peptides in juvenile rheumatic diseases: from trigger to dimmer?

  Koffeman EC, Prakken B, Albani S. Koffeman EC, et al. Curr Opin Rheumatol. 2005 Sep;17(5):600-5. doi: 10.1097/01.bor.0000171213.49876.f6. Curr Opin Rheumatol. 2005. PMID: 16093839 Review.
• Gene expression profiling in pediatric rheumatic disease: what have we learned? What can we learn?

  Jarvis JN. Jarvis JN. Curr Opin Rheumatol. 2005 Sep;17(5):606-11. doi: 10.1097/01.bor.0000171212.42252.d1. Curr Opin Rheumatol. 2005. PMID: 16093840 Review.
• Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis.

  Adams A, Lehman TJ. Adams A, et al. Curr Opin Rheumatol. 2005 Sep;17(5):612-6. doi: 10.1097/01.bor.0000169363.69066.d0. Curr Opin Rheumatol. 2005. PMID: 16093841 Review.
• Pathogenesis and treatment of Kawasaki's disease.

  Yeung RS. Yeung RS. Curr Opin Rheumatol. 2005 Sep;17(5):617-23. doi: 10.1097/01.bor.0000174184.15901.ee. Curr Opin Rheumatol. 2005. PMID: 16093842 Review.